Amorfix and Aragen Bioscience enter into agreement to develop novel monoclonal antibodies
Aragen Bioscience, Inc. and CEVEC Sign License Agreement for Human CAP® and CAP-TTM Technology
Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen
Aragen Bioscience 2010 Event Schedule
Featured Service: Assay Development
Aragen Bioscience expands labs to support rapid growth
More News & Events
